Teva Pharmaceutical Industries (TEVA) - 27 Year Stock Price History
Historical daily stock prices for Teva Pharmaceutical Industries since 1990 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Teva Pharmaceutical Industries (TEVA) as of August 18, 2017 is 17.30.
|Medical||Medical - Generic Drugs||$17.577B||$21.903B|
|TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.|